Etoposide-based therapy for severe forms of COVID-19
Kamel Hamizi, Souhila Aouidane, Ghania Belaaloui
Topics & Concepts
ARDSEtoposideHemophagocytic lymphohistiocytosisMedicineCoronavirus disease 2019 (COVID-19)Acute respiratory distressSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Supportive psychotherapyPathologicalRespiratory distressPandemicImmunologyIntensive care medicineInternal medicineLungChemotherapySurgeryDiseaseInfectious disease (medical specialty)Autoimmune and Inflammatory Disorders ResearchKawasaki Disease and Coronary ComplicationsInflammasome and immune disorders